Indication of Semaglutide Peptide :
Semaglutide peptide is a recombinant DNA-produced polypeptide analog of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents.
Efficacy and mechanism of Semaglutide Peptide
A long-acting human glucagon-like peptide-1 (GLP-1) analog developed by Novo Nordisk was subcutaneously injected once a week. It was approved by the FDA for marketing in December 2017 under the trade name Ozempic. Our company indeed provides semaglutide peptide for sale
Note: All products of Hefei KS-V Peptide are for scientific research only, not for clinical trials.